Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Hydroxyurea in Primary Progressive Multiple Sclerosis [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating hydroxyurea for primary progressive multiple sclerosis was terminated (status: TERMINATED).
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration
This clinical trial update assesses how accurately subjects used the Rebiject II injection device for multiple sclerosis in a 10-step dummy …
-
FDA approval · 2014-01-28FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approves a supplemental application for Betaseron (interferon beta-1b) from Bayer HealthCare Pharmaceuticals Inc., approving changes to …
-
FDA approval · 2014-01-28FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
FDA approved a supplemental application for COPAXONE (glatiramer acetate) submitted by Teva Neuroscience, Inc.
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis
This completed trial compared bone health effects of Copaxone versus interferon in people with multiple sclerosis, including those with low …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity [Phase 3]
Phase 3 neurophysiological study assessing Sativex for multiple sclerosis spasticity has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Robot-assisted Gait Training in Multiple Sclerosis Subjects [NA]
This entry reports that a clinical trial evaluating robot-assisted gait training for individuals with Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 clinical trial evaluating fish oil for treating depression in patients with multiple scl…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Testing the Efficacy of Self-Generation Treatment Protocol [NA]
This trial update assesses the efficacy of a self-generation treatment protocol for multiple sclerosis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Efficacy of Clean Intermittent Catheterization (CIC) in Multiple Sclerosis (MS) Patients With Bladder Dysfunction [NA]
A terminated clinical trial evaluating the efficacy of clean intermittent catheterization in multiple sclerosis patients with bladder dysfun…
-
CLINICAL_TRIALS research · 2013-12-25Clinical Trial Update: Development and Evaluation of a Cognitive Rehabilitation Program for Persons With Multiple Sclerosis [NA]
Tel Aviv University is sponsoring a clinical trial to develop and evaluate a cognitive rehabilitation program for people with multiple scler…
-
FDA approval · 2013-12-06FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for Copaxone (glatiramer acetate) submitted by Teva Neuroscience, Inc.
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis [Phase 4]
Phase 4, 6-month randomized open-label trial comparing Fingolimod (FTY720) 0.5 mg/day with a comparator in relapsing forms of multiple scler…
-
CLINICAL_TRIALS research · 2013-12-03Clinical Trial Update: Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients [NA]
A clinical trial investigates mitochondrial activity and blood lipid content in patients with multiple sclerosis; the study status is UNKNOW…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis [NA]
The clinical trial evaluating angioplasty in CCSVI for multiple sclerosis was terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Zoledronic Acid in MS-patients With Osteoporosis [Phase 3]
A Phase 3 trial of zoledronic acid in multiple sclerosis patients with osteoporosis was terminated; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment [Phase 2]
A Phase 2 trial evaluating high-dose chemotherapy with autologous stem cell transplant for patients with multiple sclerosis who had failed p…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells
This completed clinical trial investigates how microRNAs and antigen-presenting cells regulate immune responses in multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Measuring Signatures in the Fluid Surrounding the Spinal Cord in Patients Who Have Problems With Intrathecal Drug Delivery
This clinical trial update reports results from measuring signatures in the cerebrospinal fluid surrounding the spinal cord in patients with…
-
FDA approval · 2013-11-07FDA Approved: ZANAFLEX — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for ZANAFLEX (tizanidine hydrochloride) from Covis Pharma US, Inc., indicating a labeling update as …
-
FDA label_change · 2013-11-07FDA Approved: ZANAFLEX — Supplemental Application (Covis Pharma US, Inc)
The FDA approved Covis Pharma US, Inc.'s supplemental application for Zanaflex (tizanidine hydrochloride).
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Bayer/Cognitive Assessments With Multiple Sclerosis Subjects
A completed clinical trial update on cognitive assessments in multiple sclerosis subjects, conducted by the University of Louisville. The tr…
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy
This completed trial evaluated whether using multiple neutralizing antibody tests alters treatment decisions for multiple sclerosis patients…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX) [Phase 3]
This document provides long-term follow-up results from participants in the REFLEX Phase 3 trial investigating treatment for multiple sclero…
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Sodium Intake in Multiple Sclerosis
A completed clinical trial evaluating sodium intake in individuals with multiple sclerosis. The provided snippet does not include trial resu…